813 episodes

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

Empowered Patient Podcast Karen Jagoda

    • Health & Fitness
    • 4.6 • 10 Ratings

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

    Creating New Decentralized Clinical Trial Ecosystem Including Bring Your Own Physician Option with Tom Lemberg Curebase TRANSCRIPT

    Creating New Decentralized Clinical Trial Ecosystem Including Bring Your Own Physician Option with Tom Lemberg Curebase TRANSCRIPT

    Tom Lemberg is the Founder and CEO of Curebase and was recently included in the Forbes 30 under 30 list for 2022 for leading positive global change in healthcare. Curebase is shaking up the world of clinical trials by providing software for patients making it easy for them to participate from home, software for doctors that makes it easy for them to become first-time researchers, and a virtual research site model that has grown even more valuable due to the pandemic.

    Creating New Decentralized Clinical Trial Ecosystem Including Bring Your Own Physician Option with Tom Lemberg Curebase

    Creating New Decentralized Clinical Trial Ecosystem Including Bring Your Own Physician Option with Tom Lemberg Curebase

    Tom Lemberg is the Founder and CEO of Curebase and was recently included in the Forbes 30 under 30 list for 2022 for leading positive global change in healthcare. Curebase is shaking up the world of clinical trials by providing software for patients making it easy for them to participate from home, software for doctors that makes it easy for them to become first-time researchers, and a virtual research site model that has grown even more valuable due to the pandemic.

    • 19 min
    Developing Anti-Cancer Drug that Induces Immunogenic Cell Death with Dr. Joseph O’Donnell Phosplatin Therapeutics TRANSCRIPT

    Developing Anti-Cancer Drug that Induces Immunogenic Cell Death with Dr. Joseph O’Donnell Phosplatin Therapeutics TRANSCRIPT

    Dr. Joseph O'Donnell is the Chief Medical Officer at Phosplatin Therapeutics founded to develop a drug to kill cancer cells. Phosplatin is in clinical trials with PT-112 which is the first cancer therapy molecule that has a pyrophosphate on it and works by harnessing the immune system and causing immunogenic cell death. The drug is in the burgeoning field called immuno-oncology, which is using immune agents to stimulate the immune system to knock down the cancer cells.

    Developing Anti-Cancer Drug that Induces Immunogenic Cell Death with Dr. Joseph O’Donnell Phosplatin Therapeutics

    Developing Anti-Cancer Drug that Induces Immunogenic Cell Death with Dr. Joseph O’Donnell Phosplatin Therapeutics

    Dr. Joseph O'Donnell is the Chief Medical Officer at Phosplatin Therapeutics founded to develop a drug to kill cancer cells. Phosplatin is in clinical trials with PT-112 which is the first cancer therapy molecule that has a pyrophosphate on it and works by harnessing the immune system and causing immunogenic cell death. The drug is in the burgeoning field called immuno-oncology, which is using immune agents to stimulate the immune system to knock down the cancer cells.

    • 23 min
    Developing an Oral Antiviral to Fight COVID-19 and Neurodegenerative Diseases with Alain Moussy AB Science TRANSCRIPT

    Developing an Oral Antiviral to Fight COVID-19 and Neurodegenerative Diseases with Alain Moussy AB Science TRANSCRIPT

    Alain Moussy is the Co-Founder and CEO of AB Science a clinical-stage company designing and developing novel drugs to address diseases with high unmet medical needs. Masitinib, their drug in development is being investigated in neurological diseases such as amyotrophic lateral sclerosis, Alzheimer's, and multiple sclerosis as well for severe forms of COVID-19 and as an antiviral anti-protease in ambulatory COVID-19 patients.

    Developing an Oral Antiviral to Fight COVID-19 and Neurodegenerative Diseases with Alain Moussy AB Science

    Developing an Oral Antiviral to Fight COVID-19 and Neurodegenerative Diseases with Alain Moussy AB Science

    Alain Moussy is the Co-Founder and CEO of AB Science a clinical-stage company designing and developing novel drugs to address diseases with high unmet medical needs. Masitinib, their drug in development is being investigated in neurological diseases such as amyotrophic lateral sclerosis, Alzheimer's, and multiple sclerosis as well for severe forms of COVID-19 and as an antiviral anti-protease in ambulatory COVID-19 patients.

    • 16 min

Customer Reviews

4.6 out of 5
10 Ratings

10 Ratings

CyrusKrohn ,

Healthy Listening

Karen conducts thoughtful interviews with interesting guests. You’ll learn a lot about the future of the health industry from these podcasts. And you’ll be healthier because of it!

So Not Fancy ,

Great podcast for anyone who is a patient!

Karen is a great host who asks thoughtful questions of her guests and keeps it short and succinct but relevant to listeners who are trying to become better informed about the health care world.

Top Podcasts In Health & Fitness

Scicomm Media
Aubrey Gordon & Michael Hobbes
Jay Shetty
Scicomm Media
Slumber Studios
Rob Dial and Kast Media

You Might Also Like

Chemistry World
Hidden Brain